Related Experiment Video
Updated: Feb 8, 2026
07:08
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
1.5K
[Pancreatic ductal adenocarcinoma]
1Klinik für Innere Medizin, Gastroenterologie, Infektiologie, Endokrinologie und Stoffwechsel, Universitätsklinikum Giessen und Marburg GmbH, Baldinger Straße, 35043, Marburg, Deutschland. eike.gallmeier@med.uni-marburg.de.
Der Internist
|July 8, 2018
Summary
Pancreatic ductal adenocarcinoma, the most common pancreatic cancer, still has a poor prognosis despite research advances. This review covers current guidelines, epidemiology, genetics, diagnostics, and future therapies for this disease.
Area of Science:
- Oncology
- Gastroenterology
Background:
- Pancreatic ductal adenocarcinoma (PDAC) is the predominant pancreatic malignancy.
- Despite advancements, PDAC exhibits a dismal prognosis, necessitating updated clinical guidance.
Purpose of the Study:
- To provide a comprehensive review of pancreatic ductal adenocarcinoma.
- To discuss current diagnostic and therapeutic strategies based on international guidelines.
- To explore emerging aspects of PDAC, including epidemiology, genetics, and future treatment options.
Main Methods:
- Review of current German, European, and US guidelines for PDAC management.
- Synthesis of up-to-date information on PDAC epidemiology, etiopathology, and genetics.
- Discussion of established and potential future therapeutic approaches.
Main Results:
- PDAC remains a significant challenge in oncology with limited survival rates.
- Current guidelines offer a framework for diagnosis and treatment.
- Emerging research highlights key genetic factors and novel therapeutic avenues.
Conclusions:
- A comprehensive understanding of PDAC, integrating guideline-based care with emerging knowledge, is crucial.
- Continued research into epidemiology, genetics, and novel therapies is essential for improving patient outcomes.
- This review provides clinicians with updated information for managing pancreatic ductal adenocarcinoma.
Related Concept Videos
01:26Pancreatic Juice and Secretion
3.1K
Pancreatic juice is a clear fluid produced by the pancreas, containing water, salts, sodium bicarbonate, and enzymes vital for digestion in the small intestine. It helps break down large molecules, facilitating nutrient absorption.
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...
3.1K
01:27Acute Pancreatitis I: Introduction
1.3K
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
1.3K
01:24Chronic Pancreatitis I: Introduction
745
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
745
01:29Chronic Pancreatitis II: Collaborative Care
375
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
375
01:30Acute Pancreatitis II: Clinical Manifestations and Management
881
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
881
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.6K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.6K